108
Views
3
CrossRef citations to date
0
Altmetric
RAPID COMMUNICATION

Six months' treatment with lifitegrast in patients with moderate-to-severe symptomatic dry eye: a retrospective chart review

, , &
Pages 1033-1037 | Published online: 19 Jun 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alireza Shoari, Mohammad Javad Rasaee, Mozhgan Rezaei Kanavi, Sasha Afsar Aski & Raheleh Tooyserkani. (2021) In Vivo Effect of RSH-12, a Novel Selective MMP-9 Inhibitor Peptide, in the Treatment of Experimentally Induced Dry Eye Model. Current Eye Research 46:1, pages 7-13.
Read now

Articles from other publishers (2)

Alice T Epitropoulos, Sheraz M Daya, Cynthia Matossian, Alan G Kabat, Gretchen Blemker, Kristen Striffler, Laura Hendrix, Marian Macsai & Andrea Gibson. (2022) OC-01 (Varenicline Solution) Nasal Spray Demonstrates Consistency of Effect Regardless of Age, Race, Ethnicity, and Artificial Tear Use. Clinical Ophthalmology Volume 16, pages 3405-3413.
Crossref
Jing-Xing Li, Yi-Yu Tsai, Chun-Ting Lai, You-Ling Li, Ying-Hsuen Wu & Chun-Chi Chiang. (2022) Lifitegrast Ophthalmic Solution 5% Is a Safe and Efficient Eyedrop for Dry Eye Disease: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 11:17, pages 5014.
Crossref